MedCity News recently shared an article by Reese Pharmaceutical President Jeffrey Reese outlining the numerous testing options available for colorectal screening. We believe strongly that education is key to reducing colon cancer deaths in the US and appreciate MedCity News’ support as we spread awareness of colorectal cancer screening options, including self-test at-home FIT tests like our ColoTest.
A recent study JAMA Network study supports the large-scale use of FIT tests, siting that those who completed one of more FIT test screenings are associated with a 33% lower risk of death from colorectal cancer.
To learn more about FIT technology and other options for CRC screening, read the full MedCity News article here.
